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obesity, type 2 diabetes, and athero-
sclerosis. The concept of blocking
FFA binding to this protein is clearly in-
novative, but we will need more infor-
mation on possible side effects before
FABP4 inhibitors can be considered
for treating patients.
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In several species, immune signaling networks are emerging as critical modulators of disease
resistance, energy metabolism, and aging. In this issue of Cell Metabolism, Ren et al. (2007) lay the
groundwork for dissecting the mechanisms of this coordination by characterizing the interplay
between microbial pathogens and aging in the fly.Humans and the pathogens that sur-
round them are partners in a dance of
death. They are, of course, partners in
the senseof Khrushchev andKennedy,
with one always looking to surmount
the defenses of the other. Such parley
has a profound impact on aging. The
deterioration of immune function con-
tributes to the poor quality of life in
the elderly by increasing their vulnera-
bility to infection, autoimmunedisease,
andpotentially cancer (Pawelec, 1999).
In developing societies, exposure early
in life to pathogenic agents is nega-
tively correlated with life span, sug-
gesting the possibility that host-patho-
gen interactions may act acutely to
specify critical aspects of the aging
process (Finch and Crimmins, 2004).
The mechanisms underlying these
effects are of significant medical rele-
vance, and, in this issue of Cell Metab-
olism, Ren, Tower, and colleagues
(Ren et al., 2007) have begun to inves-tigate them using the fruit fly Drosoph-
ila melanogaster.
The practical limitations of mamma-
lian research on aging and immunity
have led scientists to short-livedmodel
systems such as Drosophila. Although
flies lack a truly adaptive immune re-
sponse, the genetic mechanisms in-
volved in innate immunity are highly
conserved across species. Indeed,
work in Drosophila has fostered many
advances in the mammalian system,
such as the identification of a family
of Toll-like receptors, which sense a
large spectrum of microbial patterns
(Aderem and Ulevitch, 2000). Flies are
also an important model system for
aging: several genes and pathways
that influence fly life span have human
counterparts (Longo and Finch, 2003).
One of the most striking patterns
that have emerged over the last few
years in both flies and humans is a
strong positive correlation betweenCell Metabolismage and activity of the innate immune
response. A well-recognized pheno-
type of aging in humans is chronic in-
flammation. The primary characteristic
of this condition is enhanced expres-
sion and hyperactivity of cytokine and
immune molecules, such as TNF-a,
IL-6, and NF-kB. Recent work from
several laboratories has established
that flies exhibit a similar and remark-
able upregulation of innate-immunity-
related genes with advancing age
(Landis et al., 2004; Pletcher et al.,
2002) and that the level of expression
of these genes at any age may be pre-
dictive of further life span (Landis et al.,
2004).
Using a combination of molecular
genetic assays and beautiful electron
microscopy, Ren et al. (2007) establish
that microbial load increases substan-
tially with age when flies are main-
tained using standard laboratory tech-
niques. By culturing bacteria from6, August 2007 ª2007 Elsevier Inc. 91
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PreviewsFigure 1. Fly Aging and Bacterial Load
Aging in Drosophila is normally accompanied by increased microbial load both inside and on the
surface of the fly. The expression of NF-kB effector molecules, including antimicrobial peptides,
also increases substantially with age when flies are maintained using standard laboratory tech-
niques. According to Ren et al. (2007), culturing the animals axenically or in the presence of anti-
biotics reduces both bacterial load and antimicrobial gene expression but does not impact the life
span of the fly. These data suggest that flies can withstand significant amounts of bacterial load
without increases in mortality and that infection per se is not a primary cause of death under
laboratory conditions.flies of different ages and performing
species-specific PCR amplification of
16S rDNA, they document the growth
of several species of Lactobacillus
and Acetobacter in and on aging ani-
mals. The surface of old flies, as re-
vealed by electronmicroscopy, is filled
with small spherical objects and detri-
tus-like material distributed over the
exoskeleton and concentrated in small
recessed areas. Although it is difficult
to establish conclusively, it seems
likely that these spheres are bacteria
and the detritus is a biofilm-like mate-
rial that they excrete. Flies are com-
pulsive groomers, and the number of
bacteria cells, along with their spatial
distribution and small size, paints the
picture of an ongoing struggle: the
microbes, which experience persistent
growth in harsh conditions, versus the
fly, which constantly works its hygienic
practices to limit the microbes’ relent-
less advance.
Having observed an aging-related
increase in bacterial load, Ren et al.
went on to investigate its biological im-
pact in the context of a long-standing
question: Why do flies die? Fly autop-
sies are uncommon (to say the least),
and one popular hypothesis for fly
mortality posits that death results from92 Cell Metabolism 6, August 2007 ª2007infection by harmful bacteria. The data
in the Ren et al. study seem to directly
refute this idea. Bacterial load was
reduced at all ages by culturing adult
flies axenically or in the presence of
antibiotics. The sanitized conditions
also resulted in a significant reduc-
tion in the age-dependent upregula-
tion of immune-related genes normally
observed in aging animals, including
some (but not all) antimicrobial pep-
tides. Surprisingly, however, the life
span of the flies was largely unaf-
fected. Flies are therefore capable of
withstanding significant amounts of
bacterial colonization and growth
without increases in mortality rate, and
bacterial infection per se is not a pri-
mary cause of death under laboratory
conditions (Figure 1).
As with any creative piece of sci-
ence, this work raises many questions.
For example, is the normal increase
in bacterial load the result of an immu-
nocompromised, aged host, or does it
simply reflect the increased time that
the host’s microbes have had to
grow? Monitoring age-dependent
bacterial load in flies subjected to ge-
netic or environmental manipulations
that extend life span will be informative
in this regard. It is intriguing that ex-Elsevier Inc.pression of antimicrobial peptides
continues to increase throughout the
life of the fly (upwards of 70 days)
despite measures of bacterial load
reaching a plateau sometime earlier
(roughly 24 days of age). This may re-
flect an age-dependent alteration in the
microbial composition toward more
harmful species or amore fundamental
link between immunity and aging that
is independent of microbial input.
There are also some apparent incon-
sistencies with previously published
data that should be further investi-
gated. Activation of the immune re-
sponse in the absence of infection has
been shown to be sufficient to reduce
longevity, and timed exposure to cer-
tain types of bacteria can increase life
span (Brummel et al., 2004; Libert et al.,
2006). In the Ren et al. (2007) study,
however, life span was unaffected by
antibiotic treatment despite alterations
in both immune activation and bacte-
rial exposure. One intriguing potential
resolution to this paradox is that the
reduced expression of antimicrobial
peptides in axenic conditions, which
would be predicted to result in an
increased life span, may be counter-
acted by the failure of beneficial bacte-
ria to colonize, which would result in a
reduced life span. In other words, anti-
biotic treatment may simultaneously
remove both the costs and benefits
associated with bacterial exposure.
Arising from the scourge of theBlack
Death, the DanseMacabre was a play-
ful reminder that all creatures are equal
partners in an inevitable march toward
the grave. The work of Ren et al. takes
this allegory to the microscopic level
and provides a fascinating glimpse into
the different challenges that flies face
as they age in the laboratory. Further
studies of this sort will uncover new
biological interactions that may impact
host aging and pave the way for ge-
netic analysis of age-dependent func-
tional decline and immune susceptibil-
ity. One question will always be of
central importance: In the ballet be-
tween aging host and pathogen, who
is the leader and who is the follower?
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klotho was first described as an a
vitamin D metabolism, acting as
also regulates calcium homeosta
klotho was identified as a putative
aging gene in 1997 when one of the
mouse strains created in a program
of random insertionalmutagenesiswas
found to be short-lived and displayed
atherosclerosis, osteopenia, skin at-
rophy, and pulmonary emphysema
(Kuro-o et al., 1997). Since these traits
were viewed as evidence of premature
aging, the mutation was named klotho
after the spinner of the thread of life,
one of the three Fates. The klotho gene
encodes a cell-surface protein with a
short cytoplasmic tail whose extracel-
lular domain consists of tandem dupli-
cated copies of a b-glucosidase-like
sequence, which can be released as
a soluble form of Klotho.
It was subsequently found that
klotho mutant mice had markedly in-
creased levels of calcium, phosphate,
and the active metabolite of vitamin
D, 1,25-dihydroxyvitamin D (Tsujikawa
et al., 2003). These animals die prema-
turely because their kidneys and other
tissues become calcified. This, and the
somatic features of the klotho pheno-
type, was reminiscent of mice lacking
the FGF23 gene (Urakawa et al., 2006),
which led to the observation that se-
rum levels of FGF23 were markedly
elevated in klotho mutant mice, thus
establishing that klotho is geneticallyand Tower, J. (2004). Proc. Natl. Acad. Sci.
USA 101, 7663–7668.
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ging gene and was later shown to
a coreceptor for FGF23. Imura et a
sis.
downstream of FGF23. Further exper-
iments showed that binding to Klotho
converts FGF receptors from low-
affinity to high-affinity FGF23 recep-
tors (Urakawa et al., 2006; Kurosu
et al., 2006). Imura et al. (2007) now re-
port that klotho is also a regulator of
calcium homeostasis on its own.
Most of the features that resemble
premature aging in klothomutant mice
are consequences of 1,25-dihydroxy-
vitamin D excess. The life span of
klotho mutant mice can be increased
by a vitamin D-deficient diet (Tsuji-
kawa et al., 2003). Removing the syn-
thetic enzyme for 1,25-dihydroxyvita-
min D from FGF23/ mice abolishes
all the notable features of the corre-
sponding phenotype, which are prob-
ably forms of tissue damage resulting
from chronically high calcium and
phosphate levels (Sitara et al., 2006).
The pathway by which klotho regu-
lates phosphate and vitamin D metab-
olism thus intersects with the newly
discovered FGF23 pathway. FGF23 is
a secreted phosphatonin, a factor that
induces renal phosphate wasting and
inhibits synthesis of 1,25-dihydroxyvi-
tamin D (White et al., 2006). FGF23
causes renal phosphate wasting in
both inherited and acquired forms of
hypophosphatemic rickets. The pre-
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be a regulator of phosphate and
l. (2007) now report that klotho
dominant source of FGF23 is osteo-
cytes and osteoblasts in bone, where
its secretion is repressed by dentin
matrix protein 1 (DMP1) (Liu et al.,
2006; Feng et al., 2006; Lorenz-
Depiereux et al., 2006). The secretion
of FGF23 is increased by hyperphos-
phatemia and 1,25-dihydroxyvitamin
D, but the details of its feedback
mechanisms and its physiological
role remain obscure.
klotho is expressed in only three
tissues, the distal tubule of the kid-
ney, parathyroid glands, and choroid
plexus; however, its function in these
tissues is not known. Imura et al.
(2007) report that Klotho interacts
physically with Na+/K+ ATPase in all
three of these tissues. In the choroid
plexus, Klotho binds to Na+/K+ ATP-
ase in an intracellular compartment
and a fraction of Na+/K+ ATPase ap-
pears to traffic to the cell surface with
Klotho. [3H]ouabain binding to Na+/K+
ATPase and 86Rb uptake, a measure
of Na+/K+ ATPase activity, are de-
creased, albeit slightly, in klotho/
mice. The molecular mechanism for
this effect of klotho, however, remains
to be identified.
Imura et al. show that Klotho regu-
lates some aspects of calcium homeo-
stasis. Calcium transport by the choroid
6, August 2007 ª2007 Elsevier Inc. 93
